Onkologie. 2021:15(6):302-306 | DOI: 10.36290/xon.2021.059

Cemiplimab in treatment of metastatic squamous cell carcinoma

Simona Michalčová
Kožní oddělení FN Ostrava a LF OU

Case report describe patient with metastatic squamous cell carcinoma treated with anti-PD-1 antibody cemiplimab. Cemiplimab is currently the only approved medication for locally advanced or metastatic squamous cell carcinoma.

Keywords: squamous cell carcinoma, cemiplimab.

Published: November 24, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Michalčová S. Cemiplimab in treatment of metastatic squamous cell carcinoma. Onkologie. 2021;15(6):302-306. doi: 10.36290/xon.2021.059.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Divišová B, Cetkovská P, Pizinger K. Nejčastější maligní epitelové kožní nádory. Onkologie 2010; 4(4): 230-232.
    2. Alam M, Armstrong A, Baum Ch, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 2018; 78(3): 560-578. Go to original source... Go to PubMed...
    3. Combalia A, Carrera C. Squamous Cell Carcinoma: An Update on Diagnosis and Treatment. Dermatol Pract. Conceptual 2020; 10(3): e2020066. Dostupné z: 10.5826/dpc.1003a66. eCollection 2020 Jul. Go to original source... Go to PubMed...
    4. Rischin D, Khushalani NI, Schmults ChD, et al. Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-up. Presented at American Society of Clinical Oncology (ASCO). Virtual Scientific meeting 2020: 29-31. Go to original source...
    5. Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med 2018; 379(4): 341-351. Dostupné z: 10.1056/NEJMoa1805131. Go to original source... Go to PubMed...
    6. Souhrn údajů o přípravku (SPC) Libtayo.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.